PMH15 COST-EFFECTIVENESS ANALYSIS OF LONG-ACTING RISPERIDONE (LA-RIS) VS HALOPERIDOL DECANOATE AND ORAL OLANZAPINE IN THE TREATMENT OF SCHIZOPHRENIA IN ITALY
Abstract
Authors
A DAusilio F Amaddeo C Mencacci C Munizza H Miadi-Fargier P Berto